(PharmaNewsWire.Com, February 27, 2017 ) According to Publisher, the Global Non Surgical Bio Implants Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Rising aged population, technological advancement in bio-implants, high level of healthcare awareness and rising disposable incomes are the factors driving the non-surgical bio-implants market. However, high treatment cost, increasing application areas mostly medical and aesthetic for biomaterials used in non-surgical bio-implants and reimbursement issues are the factors hindering the market.
Collagen based bio-implants holds major share owing to its lower cost and easy availability. North America region has the major market for non-surgical bio-implants in terms of revenue owing to huge number of key players and strong healthcare infrastructure. Europe region is the second leading non-surgical bio-implants market due to technical advancements in the region For more information http://www.reportsweb.com/non-surgical-bio-implants-global-market-outlook-2015-2022 . Some of the key players in the market include Novatex Bioengineering SA, LCA Pharmaceuticals, Moma Therapeutics, Inc., Johnson & Johnson, Kythera Pharmaceuticals, Inc., Anika Therapeutics, Inc., Fidia Farmaceutici, FibroGen, Inc., Hangzhou Gallop Biological Products Co. Ltd., Albiorex International BioPolymer GmbH & Co. KG, Adoderm, Nordic Aesthetics, Teoxane Laboratoires and Coapt Systems.
Regions Covered: - North America - US - Canada - Mexico - Europe - Germany - France - Italy - UK - Spain - Rest of Europe - Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific - Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: